Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 35.78% | -163.28% | 48.31% | -40.94% | 15.96% |
| Total Depreciation and Amortization | 2.27% | 0.90% | 0.45% | -5.86% | 2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16,941.67% | 112.11% | -78.83% | 613.36% | -101.13% |
| Change in Net Operating Assets | -623.70% | 27.36% | -25.96% | -104.72% | -397.84% |
| Cash from Operations | -42.75% | -7.09% | 2.92% | -27.42% | -7.06% |
| Capital Expenditure | 39.29% | 16.00% | -131.18% | 80.31% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 39.29% | 16.00% | -131.18% | 80.31% | 92.00% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.41% | 2.35% | -63.50% | -- | 28,761.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.42% | 2.35% | -64.46% | -99.99% | 28,761.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.08% | -6.07% | -337.12% | -260.47% | 255.39% |